Prenatal identification of a pathogenic maternal FGFR1 variant in two consecutive pregnancies with fetal forebrain malformations

References

• Riddle A, Nagaraj U, Hopkin RJ, et al. Fetal magnetic resonance imaging (MRI) in holoprosencephaly and associations with clinical outcome: implications for fetal counseling. J Child Neurol. 2021;36(5):1–6. doi: 10.1177/0883073820972290.
   Web of Science ®Google Scholar
• Tekendo-Ngongang C, Muenke M, Kruszka P, et al. Holoprosencephaly overview. In: Adam MP, Feldman J, Mirzaa GM, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993 [cited 2024 Feb 2]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1530/
   Google Scholar
• Rajalakshmi PP, Gadodia A, Priyatharshini P. Middle interhemispheric variant of holoprosencephaly: a rare midline malformation. J Pediatr Neurosci. 2015;10(3):244–246. doi: 10.4103/1817-1745.165678.
   PubMedGoogle Scholar
• Malta M, AlMutiri R, Martin CS, et al. Holoprosencephaly: review of embryology, clinical phenotypes, etiology and management. Children. 2023;10(4):647. doi: 10.3390/children10040647.
   PubMedGoogle Scholar
• Cohen MM. Holoprosencephaly: clinical, anatomic, and molecular dimensions. Birth Defects Res A Clin Mol Teratol. 2006;76(9):658–673. doi: 10.1002/bdra.20295.
   PubMedGoogle Scholar
• Ramakrishnan S, Gupta V. Holoprosencephaly. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2024 [cited 2024 Feb 2]. Available from: http://www.ncbi.nlm.nih.gov/books/NBK560861/
   Google Scholar
• Joó GJ, Beke A, Papp C, et al. Prenatal diagnosis, phenotypic and obstetric characteristics of holoprosencephaly. Fetal Diagn Ther. 2005;20(3):161–166. doi: 10.1159/000083897.
   PubMed Web of Science ®Google Scholar
• Chaudhari HD, Thakkar G, Darji P, et al. Prenatal ultrasound diagnosis of holoprosencephaly and associated anomalies. BMJ Case Rep. 2012;2012(2):bcr0320126129. doi: 10.1136/bcr-03-2012-6129.
   PubMedGoogle Scholar
• Leombroni M, Khalil A, Liberati M, et al. Fetal midline anomalies: diagnosis and counselling part 1: corpus callosum anomalies. Eur J Paediatr Neurol. 2018;22(6):951–962. doi: 10.1016/j.ejpn.2018.08.007.
   PubMed Web of Science ®Google Scholar
• Dubourg C, Kim A, Watrin E, et al. Recent advances in understanding inheritance of holoprosencephaly. Am J Med Genet C Semin Med Genet. 2018;178(2):258–269. doi: 10.1002/ajmg.c.31619.
   PubMed Web of Science ®Google Scholar
• Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007;369(9569):1287–1301. doi: 10.1016/S0140-6736(07)60601-1.
   PubMed Web of Science ®Google Scholar
• Kruszka P, Muenke M. Syndromes associated with holoprosencephaly. Am J Med Genet C Semin Med Genet. 2018;178(2):229–237. doi: 10.1002/ajmg.c.31620.
   PubMed Web of Science ®Google Scholar
• Dubourg C, Carré W, Hamdi-Rozé H, et al. Mutational spectrum in holoprosencephaly shows that FGF is a new major signaling pathway: human mutation. Hum Mutat. 2016;37(12):1329–1339. doi: 10.1002/humu.23038.
   PubMed Web of Science ®Google Scholar
• Cassatella D, Howard SR, Acierno JS, et al. Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures. Eur J Endocrinol. 2018;178(4):377–388. doi: 10.1530/EJE-17-0568.
   PubMed Web of Science ®Google Scholar
• Gonçalves C, Bastos M, Pignatelli D, et al. Novel FGFR1 mutations in Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism: evidence for the involvement of an alternatively spliced isoform. Fertil Steril. 2015;104(5):1261–1267.e1. doi: 10.1016/j.fertnstert.2015.07.1142.
   PubMed Web of Science ®Google Scholar
• Villanueva C, De Roux N. FGFR1 mutations in Kallmann syndrome. In: Quinton R, editor. Frontiers of hormone research [Internet]. S. Karger AG; 2010 [cited 2024 Feb 7]. p. 51–61. Available from: https://www.karger.com/Article/FullText/312693
   Google Scholar
• Palumbo P, Petracca A, Maggi R, et al. A novel dominant-negative FGFR1 variant causes Hartsfield syndrome by deregulating RAS/ERK1/2 pathway. Eur J Hum Genet. 2019;27(7):1113–1120. doi: 10.1038/s41431-019-0350-4.
   PubMed Web of Science ®Google Scholar
• Solomon BD, Retterer K, Juusola J. Holoprosencephaly: a clinical genomics perspective. Am J Med Genet C Semin Med Genet. 2018;178(2):194–197. doi: 10.1002/ajmg.c.31613.
   PubMed Web of Science ®Google Scholar
• Rich M, Schroeder B, Manning C, et al. Prenatal diagnosis of Hartsfield syndrome with a novel genetic variant. Prenat Diagn. 2023;43(13):1671–1673. doi: 10.1002/pd.6472.
   PubMed Web of Science ®Google Scholar
• Allen SK, Chandler NJ, Kinning E, et al. Diagnosis of inborn errors of metabolism through prenatal exome sequencing with targeted analysis for fetal structural anomalies. Prenat Diagn. 2023;44(4):432–442. doi: 10.1002/pd.6476.
   PubMed Web of Science ®Google Scholar
• Avram CM, Caughey AB, Norton ME, et al. Cost-effectiveness of exome sequencing versus targeted gene panels for prenatal diagnosis of fetal effusions and non-immune hydrops fetalis. Am J Obstet Gynecol MFM. 2022;4(6):100724. doi: 10.1016/j.ajogmf.2022.100724.
   PubMed Web of Science ®Google Scholar